Peter A. Thompson - 17 Jun 2022 Form 4 Insider Report for Decibel Therapeutics, Inc.

Role: Director, 10%+ Owner
Signature: /s/ Elisabeth Leiderman, Attorney-in-Fact
Issuer symbol: N/A
Transactions as of: 17 Jun 2022
Net transactions value: $0
Form type: 4
Filing time: 21 Jun 2022, 18:54:18 UTC
Previous filing: 17 Jun 2022
Next filing: 28 Jun 2022
SEC: View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	DBTX	Stock Option (right to buy)	Award	$0	+10,000		$0.000000	10,000	17 Jun 2022	Common Stock	10,000	$2.30	Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The option was granted on June 17, 2022 for 10,000 shares. The shares underlying the option are scheduled to vest in full on the one year anniversary of the date of grant of the option (or, if earlier, the date of the next annual meeting of stockholders following the date of grant of the option), subject to the reporting person's continued service.
F2	Pursuant to an agreement with OrbiMed Advisors LLC and OrbiMed Capital GP VIII LLC, the reporting person is obligated to transfer any securities issued under any such stock options or other awards, or the economic benefit thereof, to OrbiMed Advisors LLC and OrbiMed Capital GP VIII LLC, which will in turn ensure that such securities or economic benefits are provided to OrbiMed Private Investments VIII, LP.

Content

The option was granted on June 17, 2022 for 10,000 shares. The shares underlying the option are scheduled to vest in full on the one year anniversary of the date of grant of the option (or, if earlier, the date of the next annual meeting of stockholders following the date of grant of the option), subject to the reporting person's continued service.

Pursuant to an agreement with OrbiMed Advisors LLC and OrbiMed Capital GP VIII LLC, the reporting person is obligated to transfer any securities issued under any such stock options or other awards, or the economic benefit thereof, to OrbiMed Advisors LLC and OrbiMed Capital GP VIII LLC, which will in turn ensure that such securities or economic benefits are provided to OrbiMed Private Investments VIII, LP.